title: Letter by Shah and Buch regarding article, "prasugrel plus aspirin beyond 12 months is associated with improved outcomes after TAXUS Liberté paclitaxel-eluting coronary stent placement".
authors.affiliation: Peter Munk Cardiac Center, Toronto General Hospital, University Health Network, Toronto, Canada.
authors.forename: Ashish H
authors.initials: AH
authors.lastname: Shah
authors.affiliation: East Carolina Heart Institute, East Carolina University, Greenville, NC.
authors.forename: Ashesh N
authors.initials: AN
authors.lastname: Buch
mesh_terms: D001241:Aspirin / Q000627:therapeutic use*; D003327:Coronary Disease / Q000628:therapy*; D054855:Drug-Eluting Stents; D005260:Female; D006801:Humans; D008297:Male; D017239:Paclitaxel / Q000627:therapeutic use*; D010879:Piperazines / Q000627:therapeutic use*; D058921:Purinergic P2Y Receptor Antagonists / Q000627:therapeutic use*; D013876:Thiophenes / Q000627:therapeutic use*
chemical_list: D010879:Piperazines; D058921:Purinergic P2Y Receptor Antagonists; D013876:Thiophenes; D017239:Paclitaxel; D001241:Aspirin